Lokon Pharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bredgränd 14, Uppsala, Uppsala, 753 20, ...Phone Number
+46 18507444Website
www.lokonpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Lokon Pharma
Lokon Pharma is a Swedish biotech company specializing in immune oncology, focusing on immunostimulatory gene therapy for cancer treatment. The company is developing innovative tumor microenvironment gene engineering vectors aimed at addressing high unmet medical needs in patients with various cancers, including pancreatic, biliary, ovarian, and colorectal cancers. Lokon Pharma conducts clinical trials to evaluate the efficacy of its therapies, providing opportunities for eligible patients in the US and Sweden to participate. With a strong foundation in cancer biology and immunology, Lokon Pharma is at the forefront of advancing next-generation cancer immunotherapeutics.Explore more
Popular SearchesLokon Pharma ABLokon PharmaSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lokon Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Lokon Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Lokon Pharma recently announced quarterly report
Product Launch: Get notified when Lokon Pharma launches new products
Website visits: Recent activity has been detected on your website
Click to see if Lokon Pharma had a recent Job posting/layoffs
Check out if Lokon Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Lokon Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Lokon Pharma
Funding: Get notified immidiatlly once Lokon Pharma has new funding data
Recommended Actions
Reach out to Masked Content who joined Lokon Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Lokon Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lokon Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lokon Pharma.
Lokon Pharma Tech Stack
A closer look at the technologies used by Lokon Pharma
Lokon Pharma News & Media
Lokon Pharma and Affibody Initiates a Collaboration to Develop Novel Cancer Therapeutics
Uppsala and Solna, Sweden, January 12, 2022. Lokon Pharma AB, a leading biotech company in the area of immunostimulatory gene therapy for cancer delivered by uniquely engineered oncolytic viruses, today announced a collaboration with Affibody AB (“Affibody”) to combine oncolytic viruses with Affibody® molecules. “Lokon’s oncolytic adenovirus platform encodes human immunostimulatory genes to induce anti-tumor immunity in cancer patients. We already have one virus in clinical development, LOAd703,
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lokon Pharma
Sign Up For FreeTo access detailed company insights
Lokon Pharma is a Swedish biotech company specializing in immune oncology, focusing on immunostimulatory gene therapy for cancer treatment. The company is developing innovative tumor microenvironment gene engineering vectors aimed at addressing high unmet medical needs in patients with various cancers, including pancreatic, biliary, ovarian, and co... Read More
